Characteristics at clinically isolated syndrome (CIS) examination assist in identification of patient at highest risk of early second attack and could benefit the most from early disease-modifying drugs (DMDs).
Quantifying risk of early relapse in patients with first demyelinating events: Prediction in clinical practice
TROIANO, Maria;
2017-01-01
Abstract
Characteristics at clinically isolated syndrome (CIS) examination assist in identification of patient at highest risk of early second attack and could benefit the most from early disease-modifying drugs (DMDs).File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Spelman2017.pdf
non disponibili
Tipologia:
Documento in Versione Editoriale
Licenza:
NON PUBBLICO - Accesso privato/ristretto
Dimensione
197.72 kB
Formato
Adobe PDF
|
197.72 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
